Stay updated with breaking news from Nasdaq Imrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Morgan Stanley reaffirmed their equal weight rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a research report released on Friday morning, Benzinga reports. Morgan Stanley currently has a $14.00 target price on the stock. A number of other equities analysts have also weighed in on IMRX. Chardan Capital lifted their price objective on […]
Morgan Stanley reissued their equal weight rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a research note released on Friday, Benzinga reports. Morgan Stanley currently has a $14.00 price target on the stock. Other equities research analysts have also recently issued reports about the company. Chardan Capital lifted their target price on Immuneering […]
Immuneering Co. (NASDAQ:IMRX – Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 2,670,000 shares, a growth of 35.5% from the June 15th total of 1,970,000 shares. Based on an average daily volume of 122,800 shares, the […]
Immuneering Co. (NASDAQ:IMRX – Get Free Report)’s stock price dropped 2.3% during mid-day trading on Tuesday . The company traded as low as $9.76 and last traded at $9.92. Approximately 81,320 shares traded hands during mid-day trading, a decline of 3% from the average daily volume of 83,814 shares. The stock had previously closed at […]
Shares of Immuneering Co. (NASDAQ:IMRX – Get Rating) dropped 2.4% on Wednesday . The stock traded as low as $9.29 and last traded at $9.32. Approximately 82,591 shares were traded during trading, an increase of 38% from the average daily volume of 59,757 shares. The stock had previously closed at $9.55. Analyst Upgrades and Downgrades […]